Loss of imprinting of IGF2 and not H19 in breast cancer, adjacent normal tissue and derived fibroblast cultures

FEBS Letters

Volumn 437, Issue 1-2, 1998, Pages 107-111

  Van Roozendaal, C E P ^a   Gillis, A J M ^a   Klijn, J G M ^a   Van Ooijen, B ^a   Claassen, C J C ^a   Eggermont, A M M ^a   Henzen Logmans, S C ^a   Oosterhuis, J W ^a   Foekens, J A ^a   Looijenga, L H J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Genomic imprinting; Insulin like growth factor; Stromal fibroblast

Indexed keywords

SOMATOMEDIN B;

ARTICLE; BREAST CANCER; FIBROBLAST CULTURE; GENOME IMPRINTING; PRIORITY JOURNAL;

BREAST; BREAST NEOPLASMS; CELLS, CULTURED; FIBROBLASTS; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MUSCLE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, UNTRANSLATED; TUMOR CELLS, CULTURED;

EID: 0032538414     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)01211-3     Document Type: Article

References (29)

1. Bièche I., Lidereau R. Genes Chromosomes Cancer. 14:1995;227-251.
2. Garin-Chesa P., Old L.J., Rettig W.J. Proc. Natl. Acad. Sci. USA. 87:1990;7235-7239.
3. Kaczmarek J., Castellani P., Nicolo G., Spina B., Allemanni G., Zardi L. Int. J. Cancer. 58:1994;11-16.
4. Cullen K.J., Smith H.S., Hill S., Rosen N., Lippman M.E. Cancer Res. 51:1991;4978-4985.
5. van Roozendaal C.E.P., Klijn J.G.M., van Ooijen B., Claassen C., Eggermont A.M.M., Henzen-Logmans S.C., Foekens J.A. Int. J. Cancer. 65:1996;120-125.
6. Macaulay V.M. Br. J. Cancer. 65:1992;311-320.
7. Ellis M.J.C., Singer C., Hornby A., Rasmussen A., Cullen K.J. Breast Cancer Res. Treat. 31:1994;249-261.
8. Franklin G.C., Adam G.I.R., Ohlsson R. Placenta. 17:1996;3-14.
9. Looijenga L.H.J., Verkerk A.J.M.H., de Groot N., Hochberg A.A., Oosterhuis J.W. Mol. Reprod. Dev. 46:1997;419-439.
10. Zemel S., Bartolomei M.S., Tilghman S.M. Nat. Genet. 2:1992;61-65.
11. Giannoukakis N., Deal C., Paquette J., Goodyer C.G., Polychronakos C. Nat. Genet. 4:1993;98-101.
12. Zhang Y., Tycko B. Nat. Genet. 1:1992;40-44.
13. Bartolomei M.S., Webber A.L., Brunkow M.E., Tilghman S.M. Genes Dev. 7:1993;1663-1673.
14. Latham K.E., McGrath J., Solter D. Int. Rev. Cytol. 160:1995;53-98.
15. Brenton J.D., Viville S., Surani M.A. Cancer Surveys. 25:1995;161-171.
16. Weksberg R., Shen D.R., Fei Y.L., Song Q.L., Squire J. Nat. Genet. 5:1993;143-150.
17. Jarrard D.F., Bussemakers M.J.G., Bova G.S., Isaacs W.B. Clin. Cancer Res. 1:1996;1471-1478.
18. Verkerk A.J.M.H., Ariel I., Dekker M.C., Schneider T., van Gurp R.J.H.L.M., Gillis A.J.M., Oosterhuis J.W., Hochberg A.A., Looijenga L.H.J. Oncogene. 14:1997;95-107.
19. Dugimont T., Curgy J.-J., Wernert N., Delobelle A., Raes M.-B., Joubel A., Stehelin D., Coll J. Biol. Cell. 85:1995;117-124.
20. Eversole-Cire P., Ferguson-Smith A.C., Surani M.A., Jones P.A. Cell Growth Differ. 6:1995;337-345.
21. Yballe C.M., Vu T.H., Hoffman A.R. J. Clin. Endocrinol. Metab. 81:1996;1607-1612.
22. Douc-Rasy S., Barrois M., Fogel S., Ahomadegbe J.C., Stehelin D., Coll J., Riou G. Oncogene. 12:1996;423-430.
23. Zhang Y., Shields T., Crenshaw T., Hao Y., Moulton T., Tycko B. Am. J. Hum. Genet. 53:1993;113-124.
24. McCann A.H., Miller N., O'Meara A., Pedersen I., Keogh K., Gorey T., Dervan P.A. Hum. Mol. Genet. 5:1996;1123-1127.
25. Hu J.-F., Vu T.H., Hoffman A.R. J. Biol. Chem. 272:1998;20715-20720.
26. Wu H.-K., Squire J.A., Catzavelos C.G., Weksberg R. Biochem. Biophys. Res. Commun. 235:1997;123-129.
27. Okamoto K., Morison I.M., Taniguchi T., Reeve A.E. Proc. Natl. Acad. Sci. USA. 94:1997;5367-5371.
28. Rainier S., Dobry C.J., Feinberg A.P. Cancer Res. 55:1995;1836-1838.
29. Uyeno S., Aoki Y., Nata M., Sagisaka K., Kayama T., Yoshimoto T., Ono T. Cancer Res. 56:1996;5356-5359.